About this trial
This is a single-arm, two-visit, non-randomized, cross sectional study identified as an intervention due to the use of a single bout of aerobic exercise to assess cerebrovascular function under the NIH rules. This study is not masked and its primary purpose is to develop a basic science understanding of the relationship between cerebrovascular health and balance control with aging. This study will involve 102 individuals classified as younger adults, middle-aged adults, and older adults who are neurotypical and cognitively normal. The primary outcome from a clinical trials perspective will be cerebrovascular response to a bout of aerobic exercise (i.e. change in cerebral blood flow with the performance of aerobic exercise on a recumbent stepper exercise machine). Non-interventional outcomes will be EEG measures of cortical activity and biomechanical kinetic and kinematic data recorded during standing balance reactions, as well as biological blood samples for genomic analysis.
Eligibility criteria
Qualifiers
Age within the following 3 group age ranges, 21-30yo; middle-aged: 40-55yo; older: 65-95yo adults
the absence of major orthopedic disability
cognitively normal (MoCA score ≥ 26/30 in older adult group)
vision that is 20/40 or better with or without corrective lenses, (5) the ability to consent and communicate with researchers
Disqualifiers
insulin-dependent diabetes
peripheral neuropathy
myocardial infarction or symptoms of coronary artery disease within 2 years
congestive heart failure or class IV heart failure
Trial design
Treatments tested in this trial
- aerobic exercise